-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Xylem, Lowers Price Target to $154

Benzinga·04/29/2026 14:35:43
Listen to the news
Barclays analyst William Grippin maintains Xylem (NYSE:XYL) with a Overweight and lowers the price target from $156 to $154.